BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2012
View Archived Issues
Amgen presents novel TRPM8 channel antagonist
Read More
Novel antidiabetic drug Subetta evaluated in animal model
Read More
Novel deuterated analogues of mibefradil show reduced propensity for CYP3A4-mediated interactions
Read More
Studies support the use of tofogliflozin in patients with renal impairment
Read More
BioCryst Pharmaceuticals enters merger agreement
Read More
Starpharma completes recruitment in phase III VivaGel trials
Read More
Biogen Idec notified of PDUFA date extension
Read More
FDA accepts quadrivalent influenza vaccine sBLA for review
Read More
First use of CardioCel tissue patch to repair congenital heart defects
Read More
Progen Pharmaceuticals reports phase II data for PI-88 in melanoma
Read More
ProNoxis researchers synthesize new ROS production enhancers
Read More
Advinus Therapeutics presents new JAK inhibitors
Read More
Researchers describe activity of TAC-302
Read More
Trevena divulges new opioid receptor ligands
Read More
FDA committee votes to recommend approval of Kynamro
Read More
New IL-7A proteins prepared at the University of Central Florida
Read More
Phase II and III studies of bardoxolone methyl suspended
Read More
Hyundai Pharmaceutical patents new 11-beta-HSD1 inhibitors
Read More
Japanese Foundation for Cancer Research presents new antibodies
Read More
Quantum Genomics reports promising results from phase Ia trial of new antihypertensive agent
Read More
Curis achieves first milestones in CUDC-907 development
Read More
Ipsen to conduct phase II study of tasquinimod in multiple tumor types
Read More
EMA committee issues opinion on Qsiva
Read More
Pfenex receives NIH contract to develop dry formulation of rPA-based anthrax vaccine
Read More
Redx Pharma receives support to launch center for antiviral and antibacterial drugs
Read More